Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Apollo Health Ventures

Investor type Venture Capital
Founders Alexandra Bause James Peyer James Peyer Nils Regge Ole Mensching


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 10
Average round size
The average size of a deal this fund participated in
Portfolio companies 7
Rounds per year 1.67
Lead investments 3
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Biopharma
  • Health Care
  • Pharmaceutical
  • Life Science

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Apollo Health Ventures:
Typical Co-investors
Apollo Health Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Apollo Health Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Clarkston-Potomac Durham, North Carolina, United States
CP Holdings Anhui, China, Macao
Elite Network Japan, Tokyo
First Partners Holding 5 Norway, Oslo
Genesys Venture Canada, Manitoba, Winnipeg
Hefei Gaoxin Development & Investment Group Company Anhui, China, Hefei
HMC Ventures China, Hangzhou, Zhejiang
Kangmei Pharmaceutical China, Guangdong Province, Huizhou
Lumos Capital Group California, San Francisco, United States
National Treasury Management Agency (NTMA) County Dublin, Dublin, Ireland
NIIF Ltd. India, Maharashtra, Mumbai
Porte Monnaie -
Savannah Fund Kenya, Nairobi, Nairobi Area
Sejong Venture Partners Fort Lee, New Jersey, United States
Shanghai Ruiyan Touzi Guanli Co., Ltd. China, Shanghai
Squared Circles New York, New York, United States
Stage Group -
Sybat France, Gennevilliers, Ile-de-France
Zhihe Capital Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Auron Therapeutics

Health Care
$48M20 Jul 2022 Massachusetts, United States

HAYA Therapeutics

Health Care
$5M09 Feb 2022 Lausanne, Vaud, Switzerland

Bloom Science

$12M09 Dec 2021 San Diego, California, United States

Ochre Bio

Health Care
$9M16 Jun 2021 Oxford, England, United Kingdom

HAYA Therapeutics

Health Care
$19M20 May 2021 Lausanne, Vaud, Switzerland

Samsara Therapeutics

Life Science
$3M20 Dec 2019 Boston, Massachusetts, United States

Aeovian Pharmaceuticals

Health Care
$37M03 Oct 2019 San Francisco, California, United States

Samsara Therapeutics

Life Science
26 Feb 2019 Boston, Massachusetts, United States

Cleara Biotech

06 Jul 2018 Utrecht


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Apollo Health Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: